Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Novartis' spending on research and development by segment 2017-2020

This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2020, by business segment. In 2019 and 2020, in both years, the company spent almost the identical amount in billions of U.S. dollars for research and development in the Innovative Medicines division.

Novartis AG's spending on research and development by segment from 2017 to 2020

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2021

Region

Worldwide

Survey time period

2017 to 2020

Supplementary notes

All figures are rounded.
* During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's R&D expenses are not included from this year onwards.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.